Daniel Steinberger
YOU?
Author Swipe
View article: Isolation of Plasma Extracellular Vesicles for High-Depth Analysis of Proteomic Biomarkers in Metastatic Castration-Resistant Prostate Cancer Patients
Isolation of Plasma Extracellular Vesicles for High-Depth Analysis of Proteomic Biomarkers in Metastatic Castration-Resistant Prostate Cancer Patients Open
Introduction: Prostate cancer treatment has been revolutionized by targeted therapies, including PARP inhibitors, checkpoint immunotherapies, and PSMA-targeted radiotherapies. Despite such advancements, accurate patient stratification rema…
View article: Comparison of the Effect of Three Different Dietary Modifications on Myocardial Suppression in <sup>18</sup>F-FDG PET/CT Evaluation of Patients for Suspected Cardiac Sarcoidosis
Comparison of the Effect of Three Different Dietary Modifications on Myocardial Suppression in <sup>18</sup>F-FDG PET/CT Evaluation of Patients for Suspected Cardiac Sarcoidosis Open
Rationale: A definitive dietary preparation recommendation is not possible based on literature in achievement of myocardial suppression for diagnosis of cardiac sarcoidosis (CS) with 18F-FDG PET/CT. Our goal is to compare three different d…
View article: Lymphadenopathy in COVID-19 Vaccine Recipients: Diagnostic Dilemma in Oncologic Patients
Lymphadenopathy in COVID-19 Vaccine Recipients: Diagnostic Dilemma in Oncologic Patients Open
Five cases of axillary lymphadenopathy are presented, which occurred after COVID-19 vaccination and mimicked metastasis in a vulnerable oncologic patient group. Initial radiologic diagnosis raised concerns for metastasis. However, further …
View article: Clinical characteristics and organ system involvement in sarcoidosis: comparison of the University of Minnesota Cohort with other cohorts
Clinical characteristics and organ system involvement in sarcoidosis: comparison of the University of Minnesota Cohort with other cohorts Open
Background Sarcoidosis is a systemic granulomatous disease of unknown etiology. Clinical cohort studies of different populations are important to understand the high variability in clinical presentation and disease course of sarcoidosis. T…
View article: Clinical Characteristics and Organ System Involvement in Sarcoidosis: Comparison of the University of Minnesota Cohort and Other Cohorts
Clinical Characteristics and Organ System Involvement in Sarcoidosis: Comparison of the University of Minnesota Cohort and Other Cohorts Open
Background: Sarcoidosis is a systemic granulomatous disease of unknown etiology. Clinical cohort studies of different populations are important to understand the high variability in clinical presentation and disease course of sarcoidosis. …
View article: Clinical Characteristics and Organ System Involvement of the University of Minnesota Sarcoidosis Cohort
Clinical Characteristics and Organ System Involvement of the University of Minnesota Sarcoidosis Cohort Open
Background: Sarcoidosis is a systemic granulomatous disease of unknown etiology. Clinical cohort studies of different populations are important to understand the high variability in clinical presentation and disease course of sarcoidosis. …
View article: Near complete response to Pembrolizumab in microsatellite-stable metastatic sebaceous carcinoma
Near complete response to Pembrolizumab in microsatellite-stable metastatic sebaceous carcinoma Open
This is the first report describing objective clinical and radiographic responses following immunotherapy for widely metastatic sebaceous carcinoma. The dramatic therapeutic response to pembrolizumab was associated with peripheral blood ci…
View article: Poor Outcomes of Patients with Relapsed/Refractory DLBCL Requiring More Than One Salvage Therapy Followed by Autologous HCT
Poor Outcomes of Patients with Relapsed/Refractory DLBCL Requiring More Than One Salvage Therapy Followed by Autologous HCT Open
Background: Salvage therapy (ST) followed by autologous HCT (AHCT) remains the standard treatment for chemosensitive relapsed/refractory (RR) DLBCL. Approximately half of ST recipients are unable to proceed to AHCT, and often receive an al…